Photocoagulation in venous occlusive disease.
Fifty-one eyes with branch or tributary retinal venous occlusive disease underwent photocoagulation (1970-1973) after certain criteria were met: reduced visual acutity, fluorescein angiographic documentation of vessel permeability changes, and either dye leakage into the macula or neovascularization of the retina, or both. Eighty-four percent of the eyes responded to treatment with an improvement or stabilization in visual acuity, a reduction in collateral vessel caliber and permeability, and reduced dye accumlation in the macular area and increased fluorescein transit time. Photocoagulation is an affective means of reducing macular edema resulting from vascular compensatory changes following venous occlusion and decreases the risk of vitreous hemorrhage from sites of retinal neovascularization.
D003097:Collateral Circulation; D004487:Edema / Q000517:prevention & control; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D053685:Laser Therapy; D007834:Lasers; D011379:Prognosis; D012166:Retinal Hemorrhage / Q000517:prevention & control; D012169:Retinal Vein / Q000601:surgery; D013924:Thrombophlebitis / Q000601:surgery*; D014792:Visual Acuity